All companies
Visit website
Terra Biotics, Inc.
OperatingParvus Capital Corp dba Terra Biotics
Healthcare · Founded 2019
Organic Plant Nutrients
Post-money valuation ⓘ
$8.3M
As of Sep 2021 · from Terra Biotics, Inc. · pre-money + amount raised, not a traded price
Total raised
$164,570
Across 1 round since 2020
Latest share price
$10.00
Terra Biotics, Inc. offering price
Financials
FY2018–FY2024 · from SEC filings · hover any figure for its source$0
2018
$105K
−$14K
2019
$229K
−$58K
2020
$314K
−$75K
2022
$541K
$23K
2023
$259K
−$35K
2024
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2018
FY2019
FY2020
FY2022
FY2023
FY2024
Income statement
Revenue
$0
$104,817
$228,897
$313,782
$541,354
$258,829
Cost of goods sold
$0
$52,309
$132,285
$167,855
$307,714
$136,941
Gross margin
—
50%
42%
47%
43%
47%
Net income
$0
-$14,143
-$58,354
-$74,530
$23,413
-$34,595
Taxes paid
$0
$0
$0
$0
$161
$689
Balance sheet
Cash
$0
$19,288
$20,192
$7,607
$8,236
$409
Accounts receivable
$0
$16,829
$6,439
$53,333
$41,943
$60,333
Total assets
$0
$513,249
$432,986
$512,039
$522,959
$487,348
Short-term debt
$0
$52,247
$15,437
$13,769
$9,000
$9,020
Long-term debt
$0
$348,000
$362,900
$359,075
$351,352
$350,316
Total liabilities
$0
$400,247
$378,337
$372,844
$360,352
$359,336
Other
Headcount
—
3
3
—
3
3
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$8.3M
post-money
Terra Biotics, Inc.
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $164.6K / $250KInvestors 287Post-money $8.3M
Reg CF annual-report compliance
Not requiredFewer than 300 holders of record
Filed 3 of 6 annual reports (FY2020–FY2025)
287 investors
holder-count proxy
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
View all 9 filings on EDGARSource: ManualCIK 0001835501Share price $10.00
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.